Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer

Despite advances in cytotoxic chemotherapy and surgical cytoreduction, disease recurrence continues to be a troubling problem in patients with advanced-stage epithelial ovarian cancer (EOC). Malignant ascites affects approximately 10% of patients with recurrent EOC and is associated with troublesome...

Descripción completa

Detalles Bibliográficos
Autores principales: Eskander, Ramez N, Tewari, Krishnansu S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795053/
https://www.ncbi.nlm.nih.gov/pubmed/24124397
http://dx.doi.org/10.2147/CPAA.S45885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795053/
https://www.ncbi.nlm.nih.gov/pubmed/24124397
http://dx.doi.org/10.2147/CPAA.S45885

Ejemplares similares